By indication / Radiochemistry methodology
Radiochemistry methodology
15 imaging agents and 8 therapeutic agents reported for this indication. Stage reflects how far each has been taken, not what is available in any given country.
Imaging
| Agent | Isotope | Stage | Syntheses |
|---|---|---|---|
| [68Ga]Ga-FAP-2286 paired with [177Lu]Lu-FAP-2286 | Ga-68 | — | 7 |
| [18F]DAA1106 | F-18 | preclinical | 5 |
| [18F]FBEM | F-18 | Research | 3 |
| [11C]L-glutamine | C-11 | — | 2 |
| [18F]PBR102 | F-18 | preclinical | 2 |
| [89Zr]ZrCl4 | Zr-89 | — | 2 |
| [11C]phosgene | C-11 | — | 1 |
| [18F]FBAM | F-18 | preclinical | 1 |
| [18F]FCPPC | F-18 | — | 1 |
| [18F]MEL050 | F-18 | phase I | 1 |
| [18F]NS10743 | F-18 | preclinical | 1 |
| [18F](E)-PSS232 | F-18 | — | 1 |
| [68Ga]Ga-3p-C-NETA paired with [161Tb]Tb-3p-C-NETA | Ga-68 | preclinical study | 1 |
| [18F]RSO2CF2H | F-18 | Research | |
| [18F]fluoroethylazide | F-18 | — |
Therapy
| Agent | Isotope | Stage | Syntheses |
|---|---|---|---|
| [177Lu]Lu-DOTA-TOC paired with [68Ga]Ga-DOTA-TOC | Lu-177 | — | 28 |
| [225Ac]Ac-PSMA-I&T paired with [68Ga]Ga-PSMA-I&T | Ac-225 | phase I clinical trial (planned/dose escalation) | 7 |
| [211At]At-MABG | At-211 | preclinical | 7 |
| [177Lu]Lu-CTT2001 | Lu-177 | first-in-human | 2 |
| [188Re]Re-tricarbonyl(cyclopentadienylcarbonate)rhenium | Re-188 | preclinical | 2 |
| [188Re]Re-188-HYNIC-BBN | Re-188 | — | 1 |
| [211At]At-astatophenethylsuccinamate | At-211 | preclinical | 1 |
| [188Re]Re-CpTR-COOH | Re-188 | — |
Other entries
| Agent | Isotope | Stage | Syntheses |
|---|---|---|---|
| [18F]SFB | F-18 | n/a | 7 |
| [18F]FBA | F-18 | n/a | 3 |
| 2-[18F]fluoroethyl tosylate | F-18 | n/a | |
| [18F]fluoromethyl tosylate | F-18 | n/a | |
| 3-[18F]fluoropropyl tosylate | F-18 | n/a | |
| [18F]F-Py-TFP | F-18 | n/a |
Have a question?Reagents, modules, introductions to manufacturers or to specialists in your region — tell us what you need.
Get in touch